Free Trial

Rocket Pharmaceuticals (RCKTW) Competitors

Rocket Pharmaceuticals logo
$0.05 0.00 (0.00%)
As of 03/28/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RCKTW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Rocket Pharmaceuticals stock or one of its competitors? The main competitors of Rocket Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Rocket Pharmaceuticals vs.

180 Life Sciences (NASDAQ:ATNFW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings, analyst recommendations and community ranking.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Rocket Pharmaceuticals N/A N/A N/A

In the previous week, Rocket Pharmaceuticals had 5 more articles in the media than 180 Life Sciences. MarketBeat recorded 6 mentions for Rocket Pharmaceuticals and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.89 beat Rocket Pharmaceuticals' score of 0.70 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
Rocket Pharmaceuticals Positive

180 Life Sciences and Rocket Pharmaceuticals both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Rocket PharmaceuticalsN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Rocket PharmaceuticalsN/AN/AN/AN/AN/A

Summary

180 Life Sciences and Rocket Pharmaceuticals tied by winning 1 of the 2 factors compared between the two stocks.

Remove Ads
Get Rocket Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCKTW vs. The Competition

MetricRocket PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$110.43M$5.63B$7.84B
Dividend YieldN/A3.78%5.33%4.01%
P/E RatioN/A3.1423.6018.74
Price / SalesN/A4,278.81388.2390.77
Price / CashN/A12.7538.1734.64
Price / BookN/A36.766.894.23
Net IncomeN/A-$91.48M$3.20B$247.47M
7 Day PerformanceN/A-2.82%-3.06%-2.29%
1 Month PerformanceN/A59.30%1.52%-5.81%
1 Year PerformanceN/A85.98%9.37%-0.96%

Rocket Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RCKTW
Rocket Pharmaceuticals
N/A$0.05
flat
N/A-84.4%$0.00N/A0.00240News Coverage
Gap Up
ATNFW
180 Life Sciences
N/A$0.01
-3.4%
N/A-7.3%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AARD
Aardvark Therapeutics
N/A$9.25
-0.1%
$30.50
+229.7%
N/A$0.00N/A0.0018Analyst Forecast
Quiet Period Expiration
News Coverage
Gap Down
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
+0.4%
N/A-92.1%$0.00N/A0.002
AIMDW
Ainos
N/A$0.23
+21.4%
N/A+86.5%$0.00$20,729.000.0040Gap Down
ALVOW
Alvotech
N/A$1.85
+1.1%
N/A-52.7%$0.00$391.87M0.004Short Interest ↓
News Coverage
Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
flat
N/AN/A$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.06
-20.0%
N/AN/A$0.00$35.36M0.0070Positive News
Gap Down
BTMDW
biote
N/A$0.07
flat
N/A-88.1%$0.00$193.06M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.09
-7.4%
N/A-93.1%$0.00N/A0.008Short Interest ↓
News Coverage
Positive News
Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:RCKTW) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners